Overview


According to FutureWise analysis the market for corona virus vaccination and treatment in 2023 is US$ 69.48 billion, and is expected to reach US$ 22.02 billion by 2031 at a CAGR of -13.38%.

Coronaviruses, according to the WHO, are a group of viruses which cause mild illness like common cold or severe levels of illnesses like Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). These viruses are primarily transmitted from animals to humans causing respiratory infections which makes it difficult for patients to breathe. The Middle East Respiratory Syndrome is believed to have transmitted from a particular type of camel to humans while the Severe Acute Respiratory Syndrome is transmitted from civet cats to humans.

There is no defined vaccination that can prevent or treat these viruses, but it is recommended to maintain as much hygiene as possible and to take rest if a patient experiences fever. The recent outbreak in the city of Wuhan, China was initiated from its sea food market. Scientists and doctors were unable to match this virus with known ones and so it was named ‘2019-nCOV’. There is an ongoing research to understand more about the virus, what precautionary measures can be taken, how it affects the patients and what treatments need to be implemented in order to prevent it to spread further anymore.

The Corona Virus Vaccination and Treatment Market is assessed based on factors such as competitive analysis of the progress of emerging players and new entrants, the business expansion policies of key players, the financial and opportunity analysis of market players. Furthermore, the Corona Virus Vaccination and Treatment Market is analysed with respect to the patient type or treatment type, regional segmentation, application spectrum, etc. This research will be conducted with the implementation of latest market research methodologies which shall help organizations understand the overall market scenario and strategize accordingly.

  • Gilead Sciences Inc.
  • Moderna Inc.
  • Abbvie Inc.
  • Inovio Pharmaceuticals
  • Novavax Inc.
  • Protein Potential, LLC
  • AlphaVax, Inc.
  • Synairgen PLC
  • NanoViricides, Inc.
  • GeneCure, LLC.

(Note: The list of the major players will be updated with the latest market scenarios and trends)

By Patient Type

  • Humans
  • Animals
  • Aquatic Animals
  • Mammals
  • Birds

By Application

  • Hospitals
  • Clinics
  • Research and Diagnostics Laboratory

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Rest of the World (Major affected countries are China, Japan, Thailand, Nepal
  • United States of America)
  • Tier-1 Companies
  • Tier-2 Companies
  • Emerging Players
  • New Entrants
  • SWOT Analysis
  • Key Market Trends
  • Key Data -Points Affecting Market Growth
  • Revenue and Forecast Analysis
  • Growth Opportunities For New Entrants and Emerging Players
  • Key Player and Market Growth Matrix
  • To provide a comprehensive analysis on the Corona Virus Vaccination and Treatment Market By Product Type, By Application and By Region
  • To cater extensive insights on factors influencing the market growth (drivers, restraints, industry-specific restraints, business expansion opportunities,)
  • To anticipate and analyse the market size expansion in key regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- strategic alliances and mergers, technological advancements and product launches, revenue and financial analysis of key market players
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data From Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Corona Virus Vaccination and Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances

  • 5.   Global Corona Virus Vaccination and Treatment Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Corona Virus Vaccination and Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Corona Virus Vaccination and Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Corona Virus Vaccination and Treatment Market, By Patient Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Humans
        2. Animals
        3. Aquatic Animals
        4. Mammals
        5. Birds

  • 8.   Global Corona Virus Vaccination and Treatment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Research and Diagnostics Laboratory
        3. Clinics

  • 9.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Mexico
         2.3. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 14.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Gilead Sciences Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Moderna Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbvie Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Inovio Pharmaceuticals
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Novavax Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Protein Potential, LLC
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AlphaVax, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Synairgen PLC
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. NanoViricides, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. GeneCure, LLC.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 15.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 16.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients